Compare Danaher Corporation (DHR) vs Newmont Corporation (NEM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Danaher Corporation vs Newmont Corporation — how do they compare? Danaher Corporation trades at $203.89 (market cap $144.67B), while Newmont Corporation trades at $114.15 (market cap $124.17B). The key difference: Danaher Corporation is the larger of the two by market cap, and Newmont Corporation pays the higher dividend (0.88%). Which is the better fit depends on your goals.
| DHR | NEM | |
|---|---|---|
Market Cap | $144.67B | $124.17B |
Sector | Health | Basic Materials |
52-Week High | $242.05 | $131.95 |
52-Week Low | $161.91 | $67.38 |
Enterprise Value | $166.88B | $120.76B |
Dividend Yield | 0.78% | 0.88% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Danaher (DHR) trades at $204.02, down 1.65% on the day, with a bullish technical outlook supported by moving averages and a recent history of earnings beats. The company maintains strong profitability margins and positive cash flow, though revenue growth has moderated. Recent news highlights product launches and a pending acquisition of Masimo, approved by shareholders in May 2026.
The stock presents a balanced outlook with solid fundamentals and analyst support, but faces risks from integration challenges and macroeconomic pressures. Upside is supported by a consensus price target of $202.33, while valuation multiples remain elevated relative to historical norms.
Newmont Corporation (NEM) trades at $114.19, down 2.58% in the last session but maintains strong fundamentals with robust earnings beats and improving cash flow. The stock shows bullish technical signals with moving averages supporting upward momentum, though oscillators indicate potential overbought conditions. Recent developments include a $1.95 billion settlement with Barrick Mining and strategic partnerships, enhancing operational stability. Revenue growth accelerated to $22.67 billion in 2025 with net income margins expanding to 33.36%, while analyst consensus remains strongly bullish with a $133.29 price target.
NEM presents a compelling investment case driven by strong profitability, favorable gold price environment, and resolved legal uncertainties. Key opportunities include projected revenue growth to $25.8 billion in 2026 and expanding EBITDA margins. Risks include gold price volatility, production challenges, and rising operational costs. With 76% analyst buy ratings and institutional accumulation, the stock offers upside potential despite near-term technical overbought signals.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Danaher Corporation
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, including the Fortive separation in 2016, Danaher now focuses primarily on manufacturing scientific instruments and consumables in three segments: life sciences, diagnostics, and environmental and applied solutions. In late 2019, Danaher separated from its dental business through an initial public offering process, and in early 2020, it acquired GE's Biopharma business, now called Cytiva, which added to its life sciences segment.
Read more on DHR →About Newmont Corporation
Newmont Corp is primarily a gold producer with operations and/or assets in the United States, Canada, Mexico, Dominican Republic, Peru, Suriname, Argentina, Chile, Australia, and Ghana. It is also engaged in the production of copper, silver, lead and zinc. The company's operations are organized in five geographic regions: North America, South America, Australia, Africa and Nevada.
Read more on NEM →
